A major disappointment earlier this year was the announcement by Medtronic that its renal denervation system failed to ...
Renal Denervation
This channel includes news and new technology innovations for renal denervation used to treat hypertension. Renal denervation is a catheter-based therapy. The catheter is into the renal artery and delivers radio-frequency energy to ablate the nerves in the vessel wall that regulate vasoconstriction. This leaves the vessel permanently in the widest open position to allow greater blood flow to the kidneys. This enables greater filtration of the blood and removal of excess water that causes hypertension.
April 03, 2014
March 27, 2014 — Scientists at CBSET, a not-for-profit preclinical research institute dedicated to biomedical research ...
March 27, 2014By Dave Fornell, DAIC editor
Data from several cutting-edge device clinical trials will be presented as late-breakers ...
March 25, 2014
February 7, 2014 — Results from several late-breaking clinical trials will be presented during the American College of ...
February 07, 2014
January 28, 2014 — ReCor Medical advanced its Paradise System for renal denervation (RDN) for treatment resistant hypert ...
January 28, 2014
January 9, 2014 — Medtronic Inc. announced its U.S. pivotal trial for its Symplicity renal denervation system to treat ...
January 09, 2014
January 2, 2014 — Medtronic Inc. announced that the first patients were randomized in Symplicity HTN-4, which will ...
January 02, 2014
December 24, 2013 — Clinical trials for a promising new class of cholesterol-lowering medications, a long-awaited repair ...
December 24, 2013
December 6, 2013 — Medtronic Inc. announced CE mark in Europe and Therapeutic Goods Administration (TGA) listing in ...
December 06, 2013December 6, 2013 – Medtronic, Inc. presented three-year data from SYMPLICITY HTN-2, the first and longest-running ...
December 06, 2013November 13, 2013 — Petr Neuzil, M.D., Nemocnice Na Homolce Hospital, Prague, Czech Republic, presented three-month ...
November 13, 2013
November 13, 2013 — Medtronic Inc. announced that the U.S. Food and Drug Administration (FDA) has approved an ...
November 13, 2013
October 31, 2013 — Patients treated with the Boston Scientific Vessix Renal Denervation System experienced a significant ...
October 31, 2013October 28, 2013 — CBSET, a not-for-profit preclinical research institute dedicated to biomedical research, education ...
October 28, 2013
October 25, 2013 — Kona Medical Inc. announced it has closed a Series D equity financing of $10 million. Morningside ...
October 25, 2013